These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 115160)

  • 21. Influence of the combined chemotherapeutic drug tuboprim on drug metabolism.
    Mitcheva M; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1988; 14(1):35-41. PubMed ID: 3407414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the nature of pilocarpine inhibition of hepatic drug-metabolizing enzymes.
    Tsujimoto A; Dohi T
    Biochem Pharmacol; 1977 Nov; 26(21):2072-4. PubMed ID: 411496
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunochemical studies on the contribution of NADPH cytochrome P-450 reductase to the cytochrome P-450-dependent metabolism of arachidonic acid.
    Schwartzman ML; Pagano PJ; McGiff JC; Abraham NG
    Arch Biochem Biophys; 1987 Feb; 252(2):635-45. PubMed ID: 3101602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.
    Drew R; Rowell J; Grygiel JJ
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):81-93. PubMed ID: 7268211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of N1,N3-diallyluracil and N1,N3-diallylthymine on hepatic drug-metabolizing enzymes of mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):135-43. PubMed ID: 2748995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
    Hietanen E; Ahotupa M; Heikelä A; Laitinen M
    Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS; Su PK
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic mono-oxygenase activity and hepatocellular morphology in chickens treated with 3-methylcholanthrene.
    Buynitzky SJ; Wade AE; Munnell JF; Ragland WL
    Drug Metab Dispos; 1978; 6(1):1-7. PubMed ID: 23267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of 11-palmitoyloxy-delta 9-tetrahydrocannabinol with delta 9-tetrahydrocannabinol and 11-hydroxy-delta 9-tetrahydrocannabinol on the hepatic microsomal drug-metabolizing enzyme system.
    Leighty EG
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):525-35. PubMed ID: 116333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic microsomal mixed-function oxidase system in rats pretreated with cicloxilic acid.
    Casini AF; Comporti M; Subissi A; Murmann W
    Arzneimittelforschung; 1978; 28(7a):1218-20. PubMed ID: 582958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic interactions of promethazine (author's transl)].
    Pfeifer S; Borchert HH; Schuster S; Schulz H
    Pharmazie; 1981 Dec; 36(12):815-8. PubMed ID: 6799969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes.
    Chung LW; Raymond G; Fox S
    J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of propranolol, pindolol and atenolol after multiple administration in rats on the duration of hexobarbital sleeping time and on the activity of some drug-metabolizing enzyme systems.
    Kastelova A; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1993; 19(4):101-4. PubMed ID: 8203279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in rat liver monooxygenase activities after administration of atenolol, nifedipine and diltiazem alone and in combination.
    Kastelova A; Koleva M; Staneva-Stoytcheva D
    Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):627-31. PubMed ID: 11256234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsomal mixed-function oxidase activity and senescence-I. Hexobarbital sleep time and induction of components of the hepatic microsomal enzyme system in rats of different ages.
    Baird MB; Nicolosi RJ; Massie HR; Samis HV
    Exp Gerontol; 1975 Apr; 10(2):89-99. PubMed ID: 805710
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues.
    Schwartzman ML; Masferrer J; Dunn MW; McGiff JC; Abraham NG
    Curr Eye Res; 1987 Apr; 6(4):623-30. PubMed ID: 3107908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of chronic felbamate administration on anticonvulsant activity and hepatic drug-metabolizing enzymes in mice and rats.
    Swinyard EA; Woodhead JH; Franklin MR; Sofia RD; Kupferberg HJ
    Epilepsia; 1987; 28(3):295-300. PubMed ID: 3107974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol.
    Hayashi N; Kamada T; Sato N; Kasahara A; Peterson JA
    Dig Dis Sci; 1985 Apr; 30(4):334-9. PubMed ID: 2983957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.